Kåre Schultz, CEO at Teva Pharmaceutical, talks about the company's restructuring plans as well as his outlook for drug development. He says more than 90% of U.S. pharmaceuticals are generics and one out of ten drugs is produced by Teva.

Host: Jason Kelly. Producer: Doni Holloway.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com